Dewitt D S, Prough D S, Uchida T, Deal D D, Vines S M
Department of Anesthesiology, The University of Texas Medical Branch, Galveston 77555-0591, USA.
J Neurotrauma. 1997 Dec;14(12):931-41. doi: 10.1089/neu.1997.14.931.
Hemorrhage after traumatic brain injury (TBI) in cats produces significant decreases in cerebral oxygen delivery (DcereO2) and electroencephalographic (EEG) activity. To determine whether effective treatments for the separate insults of TBI and hemorrhagic shock would also prove effective after the clinically relevant combination of the two, we measured the effects of a kappa-opiate antagonist (nalmefene), an inhibitor of lipid peroxidation (tirilazad), a thyrotropin-releasing hormone analog (CG3703), a clinically useful pressor agent (dopamine) or a saline placebo on cerebral blood flow (CBF), and EEG activity after TBI and mild hemorrhagic hypotension. Cats (n = 40, 8 per group) were anesthetized with 1.6% isoflurane in N2O:O2 (70:30) and prepared for fluid-percussion TBI and microsphere measurements of CBF. Cats were randomized to receive nalmefene (1 mg/kg), tirilazad (5 mg/kg), CG3703 (2 mg/kg), dopamine (20 microg x kg(-1) x min[-1]) or a saline placebo (2 ml, 0.9% NaCl). Animals were injured (2.2 atm), hemorrhaged to 70% of preinjury blood volume, treated as just described and resuscitated with a volume of 10% hydroxyethyl starch equal to shed blood. CBF was determined and EEG activity recorded before injury, after hemorrhage, and 0, 60, and 120 min after resuscitation (R0, R60, and R120). CBF increased significantly after resuscitation (R0) in the nalmefene- and CG3703-treated groups. CBF did not differ significantly from baseline in any group at R60 or R120. DcereO2 was significantly less than baseline in the saline-, dopamine-, and tirilazad-treated groups at R60 and in the dopamine-, tirilazad-, and CG3703-treated groups at R120. EEG activity remained unchanged in the nalmefene-treated group but deteriorated significantly at R60 or R120 compared to baseline in the other groups. Nalmefene and CG3703 preserved the hyperemic response to hemodilution (otherwise antagonized by TBI), and nalmefene prevented the deterioration in DcereO2 and EEG activity that occurs after TBI and hemorrhage.
猫创伤性脑损伤(TBI)后出血会导致脑氧输送(DcereO2)和脑电图(EEG)活动显著降低。为了确定针对TBI和失血性休克这两种单独损伤的有效治疗方法在这两种损伤临床相关组合后是否也同样有效,我们测量了κ-阿片受体拮抗剂(纳美芬)、脂质过氧化抑制剂(替拉扎特)、促甲状腺激素释放激素类似物(CG3703)、一种临床常用的升压药(多巴胺)或生理盐水安慰剂对TBI和轻度失血性低血压后脑血流量(CBF)和EEG活动的影响。猫(n = 40,每组8只)用1.6%异氟醚在N2O:O2(70:30)中麻醉,并准备进行流体冲击性TBI和CBF的微球测量。猫被随机分为接受纳美芬(1 mg/kg)、替拉扎特(5 mg/kg)、CG3703(2 mg/kg)、多巴胺(20 μg·kg-1·min-1)或生理盐水安慰剂(2 ml,0.9% NaCl)。动物受伤(2.2 atm),出血至伤前血容量的70%后,按上述方法治疗,并用与失血量相等的10%羟乙基淀粉进行复苏。在受伤前、出血后以及复苏后0、60和120分钟(R0、R60和R120)测定CBF并记录EEG活动。纳美芬和CG3703治疗组复苏后(R0)CBF显著增加。在R60或R120时,任何组的CBF与基线相比均无显著差异。在R60时,生理盐水、多巴胺和替拉扎特治疗组的DcereO2显著低于基线,在R120时,多巴胺、替拉扎特和CG3703治疗组的DcereO2显著低于基线。纳美芬治疗组的EEG活动保持不变,但与其他组的基线相比,在R60或R120时显著恶化。纳美芬和CG3703保留了对血液稀释的充血反应(否则会被TBI拮抗),并且纳美芬可防止TBI和出血后DcereO2和EEG活动的恶化。